85 related articles for article (PubMed ID: 8167104)
21. In Vitro and In Vivo Potential of RH Strain of Toxoplasma gondii (Type I) in Tissue Cyst Forming.
Asgari Q; Keshavarz H; Shojaee S; Motazedian MH; Mohebali M; Miri R; Mehrabani D; Rezaeian M
Iran J Parasitol; 2013 Jul; 8(3):367-75. PubMed ID: 24454428
[TBL] [Abstract][Full Text] [Related]
22. Identification of compounds that suppress Toxoplasma gondii tachyzoites and bradyzoites.
Murata Y; Sugi T; Weiss LM; Kato K
PLoS One; 2017; 12(6):e0178203. PubMed ID: 28609444
[TBL] [Abstract][Full Text] [Related]
23. Cyst Formation from Virulent RH Strain of Toxoplasma gondii Tachyzoite: In Vitro Cultivation.
Salimi M; Shojaee S; Keshavarz H; Mohebali M
Iran J Parasitol; 2016; 11(1):81-5. PubMed ID: 27095972
[TBL] [Abstract][Full Text] [Related]
24. The effect of cyclic AMP on the growth of Toxoplasma gondii in vitro.
Choi WY; Nam HW; Youn JH; Kim DJ; Kim WK; Kim WS
Kisaengchunghak Chapchi; 1990 Jun; 28(2):71-8. PubMed ID: 2176818
[TBL] [Abstract][Full Text] [Related]
25. In vitro assessment of antimicrobial agents against Toxoplasma gondii.
Harris C; Salgo MP; Tanowitz HB; Wittner M
J Infect Dis; 1988 Jan; 157(1):14-22. PubMed ID: 3121760
[TBL] [Abstract][Full Text] [Related]
26. Granule-dependent killing of Toxoplasma gondii by CD8+ T cells.
Nakano Y; Hisaeda H; Sakai T; Zhang M; Maekawa Y; Zhang T; Nishitani M; Ishikawa H; Himeno K
Immunology; 2001 Nov; 104(3):289-98. PubMed ID: 11722643
[TBL] [Abstract][Full Text] [Related]
27. Growth inhibitory effect of bovine lactoferrin on Toxoplasma gondii tachyzoites in murine macrophages: role of radical oxygen and inorganic nitrogen oxide in Toxoplasma growth-inhibitory activity.
Tanaka T; Omata Y; Narisawa M; Saito A; Shimazaki K; Igarashi I; Hirumi H; Suzuki N
Vet Parasitol; 1997 Jan; 68(1-2):27-33. PubMed ID: 9066048
[TBL] [Abstract][Full Text] [Related]
28. Oocyst shedding by cats fed isolated bradyzoites and comparison of infectivity of bradyzoites of the VEG strain Toxoplasma gondii to cats and mice.
Dubey JP
J Parasitol; 2001 Feb; 87(1):215-9. PubMed ID: 11227895
[TBL] [Abstract][Full Text] [Related]
29. Triazine Inhibits Toxoplasma gondii tachyzoites in vitro and in vivo.
Mui EJ; Jacobus D; Milhous WK; Schiehser G; Hsu H; Roberts CW; Kirisits MJ; McLeod R
Antimicrob Agents Chemother; 2005 Aug; 49(8):3463-7. PubMed ID: 16048961
[TBL] [Abstract][Full Text] [Related]
30. Construction of Toxoplasma gondii bradyzoite expressing the green fluorescent protein.
Nishikawa Y; Zhang H; Ibrahim HM; Ui F; Ogiso A; Xuan X
Parasitol Int; 2008 Jun; 57(2):219-22. PubMed ID: 18006371
[TBL] [Abstract][Full Text] [Related]
31. Toxoplasma gondii reorganizes the host cell architecture during spontaneous cyst formation in vitro.
Paredes-Santos TC; Martins-Duarte ES; de Souza W; Attias M; Vommaro RC
Parasitology; 2018 Jul; 145(8):1027-1038. PubMed ID: 29179785
[TBL] [Abstract][Full Text] [Related]
32. Effect of nitaxozanide and pyrimethamine on astrocytes infected by Toxoplasma gondii in vitro.
Galván-Ramírez Mde L; Dueñas Jiménez JM; Rocío Rodríguez Pérez L; Troyo-Sanroman R; Ramírez-Herrera M; García-Iglesias T
Arch Med Res; 2013 Aug; 44(6):415-21. PubMed ID: 23973195
[TBL] [Abstract][Full Text] [Related]
33. [Kinetic distribution of cyst-forming Chinese isolate of Toxoplasma gondii in mice].
Wang L; Huo XX; Chen ZW; Chen H; Yu L; Song XR; Faustina HL; Luo QL; Shen JL
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2012 Jun; 30(3):179-83. PubMed ID: 23072130
[TBL] [Abstract][Full Text] [Related]
34. Effect of pyrimethamine and sulfadiazine on the fine structure and multiplication of Toxoplasma gondii in cell cultures.
Sheffield HG; Melton ML
J Parasitol; 1975 Aug; 61(4):704-12. PubMed ID: 1165554
[TBL] [Abstract][Full Text] [Related]
35. Infection of white rat peritoneal macrophages with Toxoplasma gondii, (Coccidia: Sarcocystidae) after Trypanosoma lewisi (Kinetoplastida: Trypanosomatidae) infection.
Catarinella G; Chinchilla M; Guerrero OM; Castro A
Rev Biol Trop; 1999 Sep; 47(3):483-8. PubMed ID: 10883328
[TBL] [Abstract][Full Text] [Related]
36. Identification and co-localization of perforin-like (TgPLP1) protein in Toxoplasma gondii bradyzoites.
Shan D; Qian W; Liu J; Liu R; Liu Q
Exp Parasitol; 2015 Jun; 153():39-44. PubMed ID: 25746893
[TBL] [Abstract][Full Text] [Related]
37. In Vitro and In Vivo Effects of the Bumped Kinase Inhibitor 1294 in the Related Cyst-Forming Apicomplexans Toxoplasma gondii and Neospora caninum.
Winzer P; Müller J; Aguado-Martínez A; Rahman M; Balmer V; Manser V; Ortega-Mora LM; Ojo KK; Fan E; Maly DJ; Van Voorhis WC; Hemphill A
Antimicrob Agents Chemother; 2015 Oct; 59(10):6361-74. PubMed ID: 26248379
[TBL] [Abstract][Full Text] [Related]
38. Determination of stage interconversion in vitro and in vivo by construction of transgenic Toxoplasma gondii that stably express stage-specific fluorescent proteins.
Zhang H; Zhang Y; Cao J; Zhou Y; Wang N; Zhou J
Exp Parasitol; 2013 Jul; 134(3):275-80. PubMed ID: 23545429
[TBL] [Abstract][Full Text] [Related]
39. Comparative infectivity of oocysts and bradyzoites of Toxoplasma gondii for intermediate (mice) and definitive (cats) hosts.
Dubey JP
Vet Parasitol; 2006 Aug; 140(1-2):69-75. PubMed ID: 16647212
[TBL] [Abstract][Full Text] [Related]
40. In vitro and in vivo effects of doxycycline on Toxoplasma gondii.
Chang HR; Comte R; Pechère JC
Antimicrob Agents Chemother; 1990 May; 34(5):775-80. PubMed ID: 2360817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
